Cubist Systematic Strategies, LLC - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 67 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$35,614
+223.8%
15,552
+135.6%
0.00%
Q1 2022$11,000
-80.4%
6,600
-71.6%
0.00%
-100.0%
Q4 2021$56,000
-42.3%
23,245
+15.9%
0.00%0.0%
Q3 2021$97,000
+212.9%
20,052
+947.6%
0.00%
-50.0%
Q3 2017$31,000
+3.3%
1,914
+33.9%
0.00%0.0%
Q1 2017$30,000
+275.0%
1,429
+170.6%
0.00%
+100.0%
Q4 2016$8,0005280.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$11,661,0002.42%
Telemetry Investments, L.L.C. 189,081$673,0001.14%
CHI Advisors LLC 490,877$1,748,0000.49%
BVF INC/IL 1,943,712$6,920,0000.27%
Orbimed Advisors 6,767,584$24,093,0000.21%
Novo Holdings A/S 847,906$3,019,0000.13%
Golden Green, Inc. 19,539$70,0000.06%
ALGERT GLOBAL LLC 15,467$55,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 133,700$476,0000.01%
Hikari Power Ltd 19,959$71,0000.01%
View complete list of CORVUS PHARMACEUTICALS INC shareholders